Medtronic receives FDA clearance of TrailBlazer angled peripheral support catheter


The US Food and Drug Administration (FDA) has cleared Medtronic’s TrailBlazer angled support catheter for use in the peripheral vascular system.

The TrailBlazer angled support catheter is designed to support a guide wire during access to the peripheral arteries, and to enable delivery of solutions and diagnostic agents. A Medtronic press release says that the catheter features a braided stainless steel shaft for pushability and a 25- and 30-degree angled tapered tip to access and cross complex lesions. To enhance physician visibility, each of the .014″, .018″ and .035″ guidewire compatible devices is designed with three radiopaque marker bands and a radiopaque shaft. Additionally, both the .014″ and .018″ TrailBlazer angled support catheter can fit coaxially through the .035″ support catheter for increased reach and pushability.